Antiretroviral drug expenditure, pricing and judicial demand: An analysis of federal procurement data in Brazil from 2004-2011

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Luo, Jing ^a,b   Oliveira, Maria A ^b   Ramos, Mariana B C ^c   Maia, Aurélio ^c   Osorio De Castro, Claudia G S ^b  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c MINISTÉRIO DA SAÚDE   (Brazil)

Author keywords

Access to medicines; Antiretroviral treatment; Brazil; Drug procurement; HIV AIDS; Judicial demand

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GENERIC DRUG;

ADULT; BRAZIL; COMMERCIAL PHENOMENA; DRUG COST; ECONOMICS; HEALTH CARE COST; HIV INFECTIONS; HUMAN; INTERPERSONAL COMMUNICATION; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; UNITED STATES;

ADULT; ANTI-HIV AGENTS; BRAZIL; COMMERCE; DRUG COSTS; DRUGS, GENERIC; HEALTH EXPENDITURES; HIV INFECTIONS; HUMANS; NEGOTIATING; PRIVATE SECTOR; UNITED STATES;

EID: 84900415305     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-367     Document Type: Article

References (30)

1. Antiretroviral treatment in resource-poor settings: the Brazilian experience. Teixeira PR, Vitória MA, Barcarolo J, AIDS 2004 18 5 S7 10.1097/00002030-200406003-00002 15322477
2. Access to antiretroviral drugs in Brazil. Galvão J, Lancet 2002 360 9348 1862 1865 10.1016/S0140-6736(02)11775-2 12480377
3. Fighting against AIDS: the Brazilian experience. Levi GC, Vitória MAA, AIDS 2002 16 18 2373 2383 10.1097/00002030-200212060-00001 12461410
4. Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives. Greco DB, Simao M, AIDS 2007 21 37
5. Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand. Ford N, Wilson D, Chaves GC, Lotrowska M, Kijtiwatchakul K, AIDS 2007 21 21 S29
6. Fighting HIV-lessons from Brazil. Okie S, N Engl J Med 2006 354 19 1977 1981 10.1056/NEJMp068069 16687709
7. Sustainability of Brazilian policy for access to antiretroviral drugs. Grangeiro A, Teixeira L, Bastos FI, Teixeira P, Rev Saude Publica 2006 40 60 69 16729160
8. Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment. Nunn AS, Fonseca EM, Bastos FI, Gruskin S, Salomon JA, PLoS Med 2007 4 11 305 10.1371/journal.pmed.0040305 18001145
9. Modeling HIV/AIDS drug price determinants in Brazil: is generic competition a myth? Meiners C, Sagaon-Teyssier L, Hasenclever L, Moatti JP, PLoS One 2011 6 8 23478 10.1371/journal.pone.0023478 21858138
10. Santos RSLD, Sustenabilidade do Programa Nacional de DST/AIDS: Analise da Capacidade de Oferta e Precos dos Medicamentos Antiretrovirais Rio de Janeiro: Universidade Federal do Rio de Janeiro 2010
11. Progress Report on the Brazilian Response to HIV/AIDS (2010-2011). Brazilian Ministry of Health, Health Surveillance Secretariat, Department of STD, AIDS and Viral Hepatitis, Geneva, Switzerland: UNAIDS 2012 http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/ 2012countries/UNGASS-2012-ingles-rev-08jun.pdf
12. Building the foundations for the response to HIV/AIDS in Brazil: the development of HIV/AIDS policy, 1982-1996. Parker R, Divulgação em Saúde para Debate 2003 27 143 183
13. Compulsory license and access to medicines: economic savings of efavirenz in Brazil. Viegas F, Neves da Silva RH, Guimarães A, XIX International AIDS Conference: July 25, 2012 2012 Washington DC, USA: International AIDS Society 2012 http://www.jiasociety.org/index.php/jias/article/view/18442/1249
14. Reis R, Vieira MF, Chaves G, Intellectual property rights and access to ARV medicines: civil society resistance in the global South Rio de Janeiro: Brazilian Interdisciplinary AIDS Association 2009
15. Brazil and access to HIV/AIDS drugs: a question of human rights and public health. Galvão J, Am J Public Health 2005 95 7 1110 1116 10.2105/AJPH.2004.044313 15933238
16. WHO, Introduction to drug utilization research Geneva, Switzerland: World Health Organization 2003
17. ATC/DDD Index. http://www.whocc.no/atc-ddd-index/
18. Number of patients in ARV therapy. Department of STD/AIDS and Viral Hepatitis, Ministry of Health of Brazil, Brasilia, Brazil: Department of STD/AIDS and Viral Hepatitis, Ministry of Health 2011 http://sistemas.aids.gov. br/monitoraids
19. Consensus Treatment Recommendations. http://www.aids.gov.br/pagina/ recomendacoes-de-tratamento-consensos
20. Foreign Exchange Rates. http://www.federalreserve.gov/releases/h10/ current/
21. AIDS treatment in Brazil: impacts and challenges. Nunn AS, da Fonseca EM, Bastos FI, Gruskin S, Health Aff 2009 28 4 1103 1113 10.1377/hlthaff.28.4.1103
22. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health? Oliveira MA, Bermudez JAZ, Chaves GC, Velásquez G, Bull World Health Organ 2004 82 11 815 821 15640916
23. Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials. Katlama C, Haubrich R, Lalezari J, Lazzarin A, Madruga JV, Molina JM, Schechter M, Peeters M, Picchio G, Vingerhoets J, AIDS 2009 23 17 2289 10.1097/QAD. 0b013e3283316a5e 19710593
24. Rational therapeutics: health-related elements in lawsuits demanding medicines. Sant'Ana JMB, Pepe VLE, Figueiredo TA, Osorio-de-Castro CGS, Ventura M, Rev Saude Publica 2011 45 4 714 721 10.1590/S0034-89102011005000042 21739079
25. Um enfoque sanitário sobre a demanda judicial de medicamentos. Figueiredo TA, Pepe VLE, Osorio-de-Castro CGS, Physis Rev Saude Colet 2010 20 1 101 118
26. Distorções causadas pelas ações judiciais à política de medicamentos no Brasil. Vieira FS, Zucchi P, Rev Saude Publica 2007 41 2 214 222 10.1590/S0034-89102007000200007 17384795
27. Mandados judiciais como ferramenta para garantia do acesso a medicamentos no setor público: a experiência do Estado do Rio de Janeiro Brasil. Messeder AM, Osorio-de-Castro CGS, Luiza VL, Cad Saude Publica 2005 21 2 525 534 10.1590/S0102-311X2005000200019 15905915
28. Judicialisation of the right to health in Brazil. Biehl J, Petryna A, Gertner A, Amon JJ, Picon PD, Lancet 2009 373 9682 2182 2184 10.1016/S0140-6736(09)61172-7 19560587
29. Transaction Prices for Antiretroviral Medicines from 2009 to 2012. Mechanism WGPR, Geneva, Switzerland: World Health Organization 2012 http://www.who.int/hiv/pub/amds/gprm2013/en/index.html
30. Panorama do status patentario e registro sanitario dos medicamentos antiretrovirais no Brazil: implicacoes para o acesso e para a politica industrial de saude. Villardi P, Associacao Brasileira Interdisciplinar de AIDS 2012